CD41 - Histology

What is CD41?

CD41, also known as Glycoprotein IIb (GPIIb), is a protein found on the surface of platelets and certain other cells. It plays a crucial role in platelet aggregation and is essential for normal clotting. CD41 is a part of the integrin αIIbβ3 complex, which is vital for cell adhesion and signal transduction.

Where is CD41 Expressed?

CD41 is primarily expressed on the surface of platelets and megakaryocytes, the precursor cells that give rise to platelets. Additionally, CD41 can be found on certain subsets of hematopoietic stem cells and progenitor cells, making it a valuable marker for identifying and studying these cells.

What is the Function of CD41?

The primary function of CD41 is to mediate platelet aggregation, which is essential for the formation of a hemostatic plug during blood clotting. CD41, in conjunction with CD61 (β3 integrin), forms the αIIbβ3 integrin complex that binds to fibrinogen and other adhesive proteins, facilitating platelet-platelet interactions.

How is CD41 Used in Histology?

In histology, CD41 is commonly used as a cell marker to identify and study platelets, megakaryocytes, and certain hematopoietic cells. Immunohistochemistry (IHC) techniques employing anti-CD41 antibodies are widely utilized to visualize these cells in tissue sections. This is particularly important in the diagnosis and research of hematologic disorders and in stem cell research.

What are the Clinical Implications of CD41?

Alterations in CD41 expression or function can have significant clinical implications. For instance, mutations in the gene encoding CD41 (ITGA2B) can lead to Glanzmann thrombasthenia, a rare bleeding disorder characterized by defective platelet aggregation. Additionally, CD41 is used as a marker in the diagnosis of certain leukemias and other hematological malignancies.

Research and Future Directions

Ongoing research is exploring the roles of CD41 in various biological processes beyond hemostasis, including its involvement in stem cell regulation and immune response. Advances in understanding CD41 signaling pathways and interactions could provide new insights into disease mechanisms and potential therapeutic targets.



Relevant Publications

Partnered Content Networks

Relevant Topics